The use of colony stimulating factors in clinical bone marrow transplantation is rapidly evolving. Both granulocyte colony stimulating factor and granulocyte macrophage colony stimulating factor have shown efficacy in bone marrow transplant patients in accelerating the rate of myeloid recovery. The
β¦ LIBER β¦
Clinical use of rHuEPO in bone marrow transplantation
β Scribed by Sven Klaesson
- Publisher
- Springer US
- Year
- 1999
- Tongue
- English
- Weight
- 564 KB
- Volume
- 16
- Category
- Article
- ISSN
- 1357-0560
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The use of colony stimulating factors in
β
Robert S Negrin; Peter L Greenberg
π
Article
π
1992
π
Elsevier Science
π
English
β 508 KB
The use of immunoglobulin in bone marrow
β
Peter J. Tutschka
π
Article
π
1990
π
Springer
π
English
β 710 KB
Bone marrow transplantation βClinical re
β
Speck, Bruno
π
Article
π
1973
π
Springer-Verlag
β 347 KB
Clinical pharmacokinetics of ciclosporin
β
Pierre Bertault-Pérès; Dominique Maraninchi; Yves Carcassonne; Jean-Paul Cano; J
π
Article
π
1985
π
Springer
π
English
β 539 KB
Tolerance induction using bone marrow tr
β
Ascher, Nancy L.
π
Article
π
1998
π
Wiley (John Wiley & Sons)
π
English
β 52 KB
Background: Animals reconstituted with allogeneic whole bone marrow (WBM) are often tolerant of donor-specific solid organ grafts. Clinical application of bone marrow transplantation in solid organ transplantation has been limited, however, principally by graft-versus-host disease. We previously dem
MR appearances of bone marrow in childre
β
A. E. Boothroyd; G. Sebag; F. Brunelle
π
Article
π
1991
π
Springer-Verlag
π
English
β 503 KB